晚期卵巢癌肿瘤细胞减灭术后的生活质量:在国际前瞻性SOCQER-2队列研究中探讨疾病负荷与手术复杂性之间的关联
该国际前瞻性多中心观察性研究纳入接受低、中、高手术复杂性评分(SCS)肿瘤细胞减灭术的晚期卵巢癌患者,评估生活质量变化。结果显示三组EORTC QLQ-C30全局评分随时间均有小幅统计学显著改善(p<0.001),高SCS组术后6周身体、角色和情绪功能出现轻中度下降,但在6-12个月内恢复。
要点
- 低、中、高SCS组术后12个月全局生活质量均改善,高SCS组并不更差。
- 重复测量模型显示三组间EORTC QLQ-C30全局评分无临床或统计学意义差异(p=0.840)。
- 高SCS组术后6周身体(p=0.004)、角色(p=0.016)和情绪(p=0.001)功能出现轻中度下降,6-12个月内恢复。
核心结论
- 接受低、中、高SCS手术的患者术后12个月全局生活质量均改善,接受广泛手术的患者生活质量并未更差。
研究设计与样本
- 前瞻性多中心观察性研究,纳入英国、印度加尔各答和澳大利亚墨尔本的妇科癌症手术中心接受手术切除(低、中或高SCS)的晚期卵巢癌患者。
主要发现
- EORTC QLQ-C30全局评分较术前基线的平均变化:术后6周低SCS组为3.4(SD 1.8,n=88),中SCS组为4.0(SD 2.1,n=55),高SCS组为4.3(SD 2.1,n=52)(p=0.048)。
- 术后12个月低SCS组为4.3(SD 2.1,n=51),中SCS组为5.1(SD 2.2,n=41),高SCS组为5.1(SD 2.2,n=35)(p=0.133)。
- 重复测量模型显示三组间EORTC QLQ-C30全局评分无临床或统计学意义差异(p=0.840),但所有组随时间均有小幅统计学显著改善(p<0.001)。
- 高SCS组术后6周身体功能(p=0.004)、角色功能(p=0.016)和情绪功能(p=0.001)出现轻中度下降,6-12个月内恢复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate quality of life (QoL) and association with surgical complexity and disease burden after surgical resection for advanced ovarian cancer in centres with variation in surgical approach. DESIGN: Prospective multicentre observational study. SETTING: Gynaecological cancer surgery centres in the UK, Kolkata, India, and Melbourne, Australia. SAMPLE: Patients undergoing surgical resection (with low, intermediate or high surgical complexity score, SCS) for late-stage ovarian cancer. MAIN OUTCOME MEASURES: Primary: change in global score on the European Organisation for Research and Treatment of Cancer (EORTC) core quality-of-life questionnaire (QLQ-C30). Secondary: EORTC ovarian cancer module (OV28), progression-free survival. RESULTS: Patients' preoperative disease burden and SCS varied between centres, confirming differences in surgical ethos. QoL response rates were 90% up to 18 months. Mean change from the pre-surgical baseline in the EORTC QLQ-C30 was 3.4 (SD 1.8, n = 88) in the low, 4.0 (SD 2.1, n = 55) in the intermediate and 4.3 (SD 2.1, n = 52) in the high-SCS group after 6 weeks (p = 0.048), and 4.3 (SD 2.1, n = 51), 5.1 (SD 2.2, n = 41) and 5.1 (SD 2.2, n = 35), respectively, after 12 months (p = 0.133). In a repeated-measures model, there were no clinically or statistically meaningful differences in EORTC QLQ-C30 global scores between the three SCS groups (p = 0.840), but there was a small statistically significant improvement in all groups over time (p < 0.001). The high-SCS group experienced small to moderate decreases in physical (p = 0.004), role (p = 0.016) and emotional (p = 0.001) function at 6 weeks post-surgery, which resolved by 6-12 months. CONCLUSIONS: The global QoL of patients undergoing low-, intermediate- and high-SCS surgery improved at 12 months after surgery and was no worse in patients undergoing extensive surgery. TWEETABLE ABSTRACT: Compared with surgery of lower complexity, extensive surgery does not result in poorer quality of life in patients with advanced ovarian cancer.
引用
- Sundar S, Cummins C, Kumar S, et al. Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study. BJOG. 2022. PMID: 34865316. doi:10.1111/1471-0528.17041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。